Company
Corvus Pharmaceuticals, Inc. (CRVS)
Standardized SEC financial data for Corvus Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001626971 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-25.0%
Free cash flow
-$33.0M
Current ratio
6.21×
EPS (diluted)
$-0.53
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $31.8M | $29.1M | $24.5M | $16.5M | $19.4M | $33.7M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $44.3M | $69.5M | $42.3M | $27.1M | $52.0M | $56.8M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$34.8M | -$36.7M | -$27.0M | -$23.9M | -$25.4M | -$32.8M |
| Capital expenditures |
Get CRVS data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CRVS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CRVS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"